RARE - Ultragenyx Pharmaceutical Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - RARE (1515673)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
39 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-10-10
RAREHorn HowardCFOS - Sale$52.76-7,46592,301-7%-$393,853
2024-09-03
RAREKakkis Emil DPres, CEOS - Sale$55.85-20,0002,788,582-1%-$1,117,000
2024-09-03
RAREHuizenga Theodore AlanSVP, Chief Accounting OfficerS - Sale$56.19-9141,5510%-$5,113
2024-08-06
RAREKakkis Emil DPres, CEOS - Sale$50.17-20,0002,808,582-1%-$1,003,400
2024-07-02
RARESanders Corazon (Corsee) D.DirS - Sale$40.98-58412,009-5%-$23,932
2024-06-12
RAREParschauer Karah HerdmanEVP, GCS - Sale$45.00-9,80657,981-14%-$441,270
2024-06-10
RARESanders Corazon (Corsee) D.DirS - Sale$41.10-1,7377,248-19%-$71,391
2024-05-02
RARECrombez EricEVP, Chief Medical OfficerS - Sale$43.66-35448,431-1%-$15,456
2024-04-18
RARECrombez EricEVP, Chief Medical OfficerS - Sale$44.10-14248,7850%-$6,262
2024-03-11
RAREKassberg Thomas RichardCBO, EVPS - Sale$49.93-11,509252,823-4%-$574,644
2024-03-07
RAREFust Matthew KDirS - Sale$50.88-12,19514,860-45%-$620,443
D
2024-03-01
RAREParschauer Karah HerdmanEVP, GCS - Sale+OE$53.76-3,75667,340-5%-$201,923
D
2024-03-01
RAREKassberg Thomas RichardCBO, EVPS - Sale+OE$53.76-1,011264,3320%-$54,351
D
2024-03-01
RAREPinion John RichardSee RemarksS - Sale+OE$53.76-4,17389,268-4%-$224,340
D
2024-03-01
RAREHuizenga Theodore AlanSVP, Chief Accounting OfficerS - Sale+OE$53.76-34141,380-1%-$18,332
D
2024-03-01
RARECrombez EricEVP, Chief Medical OfficerS - Sale+OE$53.76-1,23848,927-2%-$66,555
D
2024-03-01
RAREHarris ErikEVP, Chief Commercial OfficerS - Sale+OE$53.76-4,76867,163-7%-$256,328
2024-02-07
RAREKakkis Emil DPres, CEOS - Sale$45.00-30,0002,803,755-1%-$1,350,000
2023-12-29
RAREKakkis Emil DPres, CEOS - Sale$47.87-30,0002,833,755-1%-$1,436,100
D
2023-10-23
RAREKassberg Thomas RichardCBO, EVPS - Sale+OE$32.78-39,878246,860-14%-$1,307,201
D
2023-10-19
RAREKakkis Emil DPres, CEOS - Sale+OE$33.52-47,8532,863,728-2%-$1,604,033
D
2023-09-07
RAREHuizenga Theodore AlanSVP, Chief Accounting OfficerS - Sale+OE$40.80-2,16323,614-8%-$88,249
2023-09-05
RAREHarris ErikEVP, Chief Commercial OfficerS - Sale$37.96-6,00051,281-10%-$227,760
2023-09-01
RAREHuizenga Theodore AlanSVP, Chief Accounting OfficerS - Sale$37.15-97023,777-4%-$36,032
2023-06-30
RARESanders Corazon (Corsee) D.DirS - Sale$46.76-5858,985-6%-$27,355
2023-06-19
RAREHarris ErikEVP, Chief Commercial OfficerS - Sale$48.20-30557,281-1%-$14,701
D
2023-06-08
RARESanders Corazon (Corsee) D.DirS - Sale+OE$51.65-1,4859,570-13%-$76,700
2023-05-18
RAREPinion John RichardSee RemarksS - Sale$50.00-2,01274,744-3%-$100,600
2023-05-04
RAREParschauer Karah HerdmanEVP, GCS - Sale$45.00-4,37851,982-8%-$197,010
2023-03-01
RAREBedrosian Camille LEVP, Chief Medical OfficerS - Sale$45.25-3,88146,720-8%-$175,615
D
2023-03-01
RAREParschauer Karah HerdmanEVP, GCS - Sale+OE$45.25-3,16156,139-5%-$143,035
D
2023-03-01
RAREKassberg Thomas RichardCBO, EVPS - Sale+OE$45.27-1,968246,860-1%-$89,091
D
2023-03-01
RAREHuizenga Theodore AlanSVP, Chief Accounting OfficerS - Sale+OE$45.65-10021,7150%-$4,565
D
2023-03-01
RAREHuang Dennis KarlSee RemarksS - Sale+OE$45.65-38964,715-1%-$17,758
D
2023-03-01
RAREPinion John RichardSee RemarksS - Sale+OE$45.26-3,75576,160-5%-$169,951
D
2023-03-01
RAREHarris ErikEVP, Chief Commercial OfficerS - Sale+OE$45.25-3,66457,344-6%-$165,796
2023-02-28
RAREHuizenga Theodore AlanSVP, Chief Accounting OfficerS - Sale$43.40-63915,558-4%-$27,733
2022-12-30
RAREKakkis Emil DPres, CEOS - Sale$45.57-19,5822,824,385-1%-$892,352
2022-12-21
RAREHuizenga Theodore AlanSVP, Chief Accounting OfficerS - Sale$43.96-2,03116,197-11%-$89,283

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top